摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(Z)-1-((2-hydroxynaphthalen-3-yl)methyl)-3-(1-methyl-2-oxoindolin-3-ylidene) thiourea

中文名称
——
中文别名
——
英文名称
(Z)-1-((2-hydroxynaphthalen-3-yl)methyl)-3-(1-methyl-2-oxoindolin-3-ylidene) thiourea
英文别名
(3Z)-1-[(3-hydroxynaphthalen-2-yl)methyl]-3-(1-methyl-2-oxoindol-3-ylidene)thiourea
(Z)-1-((2-hydroxynaphthalen-3-yl)methyl)-3-(1-methyl-2-oxoindolin-3-ylidene) thiourea化学式
CAS
——
化学式
C21H17N3O2S
mdl
——
分子量
375.451
InChiKey
MZOQJWDNYAZPNA-NMWGTECJSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    27
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.1
  • 拓扑面积:
    97
  • 氢给体数:
    2
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    聚合甲醛1-甲基靛红硫脲2-萘酚对甲苯磺酸 作用下, 以 乙醇 为溶剂, 反应 36.0h, 以75%的产率得到(Z)-1-((2-hydroxynaphthalen-3-yl)methyl)-3-(1-methyl-2-oxoindolin-3-ylidene) thiourea
    参考文献:
    名称:
    N-取代的羟基萘亚氨基-羟吲哚衍生物作为新型的PI3-激酶抑制剂和乳腺癌药物:分子验证和结构-活性关系研究
    摘要:
    N-取代的羟基亚氨基亚氨基-羟吲哚衍生物(5a–g)作为磷酸肌醇3-激酶(PI3K)的抑制剂出现,PI3K是细胞凋亡或程序性细胞死亡的重要调节剂。获得了电子供体/受体取代的吲哚亚胺(5a–g),并通过FTIR,1H NMR,13C NMR和HRMS阐明了结构。通过竞争性ELISA评估PI3K的抑制能力。随后,评估了对乳腺癌(MCF-7)细胞系的抗癌活性。在两种活性中,化合物5c,5d和5f显示出最有效的活性。抗癌活性的抑制百分比为78.​​22±1.02(5c)和78.98±1.08(5f),并且IC 50为2.02±0.92μ米(图5c)和1.98±0.18μ米(图5f)。发现化合物5a和5g对两种活性均无活性,其余的均显示中等活性。为了更深入地了解结合模式和抑制剂的结合亲和力,将5a–g对接至PI3Ksp110α(PDB ID:2ENQ)的活性位点。结果表明,PI3Ks的结合口袋中的疏
    DOI:
    10.1111/cbdd.13079
点击查看最新优质反应信息

文献信息

  • Therapeutic investigations of novel indoxyl-based indolines: A drug target validation and Structure-Activity Relationship of angiotensin-converting enzyme inhibitors with cardiovascular regulation and thrombolytic potential
    作者:A. Manikandan、Pearl Moharil、M. Sathishkumar、C. Muñoz-Garay、A. Sivakumar
    DOI:10.1016/j.ejmech.2017.09.076
    日期:2017.12
    A family of 12 members of Naphthalene-2-ol-indolin-2-one-thiocarbamides (5a-1) with pharmacological potentials of cardiovascular modulator were efficiently synthesized and evaluated. These compounds show inhibitory activity on angiotensin-converting enzyme (ACE), which is a principal constituent of the renin angiotensin system and causative source for hypertension (HTN) (elevated blood pressure) and congestive heart failure (CHF), a parameter that was tested in this report. Prior to this, to get more insight into the binding mode and inhibition of human ACE C-domain (PDB ID: 2XY9) and N-domain (PDB ID: 3NXQ) compounds 5a-1 was docked into the active site of them. The established inhibitory constant (Ki) (range 40-500 nM) and least binding affinities (-18.52 to 30.57 kcal/mol) indicated the therapeutic selectivity of compounds 5a-1 towards ACE C-domain inhibition over ACE N-domain. The cytotoxicity effect of most potent compounds among 5a-1 were tested in normal breast cells and MCF-7 cell lines. Simultaneously, H2O2 induced antioxidant and DNA damage assessment was executed. Eventually, a thrombolytic activity followed by a human red blood cell (HRBC) membrane stabilization study to ensure the relaxation of blood and stabilization of RBC was executed. Structure-Activity Relationship (SAR) study discloses the potential of 5c, 5h, and 5k as cardiovascular protective therapeutic agents among 5a-1. (C) 2017 Elsevier Masson SAS. All rights reserved.
  • N-substituted hydroxynaphthalene imino-oxindole derivatives as new class of PI3-kinase inhibitor and breast cancer drug: Molecular validation and structure-activity relationship studies
    作者:M. Rajesh Kumar、Manikandan Alagumuthu、V. Violet Dhayabaran
    DOI:10.1111/cbdd.13079
    日期:2018.1
    N-substituted hydroxynaphthalene imino-oxindole derivatives (5a–g) were emerged as the inhibitors of the phosphoinositide 3-kinase (PI3K), which is a crucial regulator of apoptosis or programmed cell death. Electron donor-/acceptor-substituted indole-imine (5a–g) was achieved, and the structures were elucidated by FTIR, 1H NMR, 13C NMR and HRMS. Inhibition potency of PI3Ks was assessed by competitive
    N-取代的羟基亚氨基亚氨基-羟吲哚衍生物(5a–g)作为磷酸肌醇3-激酶(PI3K)的抑制剂出现,PI3K是细胞凋亡或程序性细胞死亡的重要调节剂。获得了电子供体/受体取代的吲哚亚胺(5a–g),并通过FTIR,1H NMR,13C NMR和HRMS阐明了结构。通过竞争性ELISA评估PI3K的抑制能力。随后,评估了对乳腺癌(MCF-7)细胞系的抗癌活性。在两种活性中,化合物5c,5d和5f显示出最有效的活性。抗癌活性的抑制百分比为78.​​22±1.02(5c)和78.98±1.08(5f),并且IC 50为2.02±0.92μ米(图5c)和1.98±0.18μ米(图5f)。发现化合物5a和5g对两种活性均无活性,其余的均显示中等活性。为了更深入地了解结合模式和抑制剂的结合亲和力,将5a–g对接至PI3Ksp110α(PDB ID:2ENQ)的活性位点。结果表明,PI3Ks的结合口袋中的疏
查看更多